The evidence base for circulating tumour DNA blood-based biomarkers for the early detection of cancer: A systematic mapping review

The presence of circulating cell-free DNA from tumours in blood (ctDNA) is of major importance to those interested in early cancer detection, as well as to those wishing to monitor tumour progression or diagnose the presence of activating mutations to guide treatment. | The evidence base for circulating tumour DNA blood-based biomarkers for the early detection of cancer A systematic mapping review

TÀI LIỆU LIÊN QUAN
TỪ KHÓA LIÊN QUAN